Strs Ohio decreased its position in LHC Group (NASDAQ:LHCG) by 12.9% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,800 shares of the health services provider’s stock after selling 1,900 shares during the period. Strs Ohio’s holdings in LHC Group were worth $868,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Eqis Capital Management Inc. increased its stake in LHC Group by 0.8% in the first quarter. Eqis Capital Management Inc. now owns 6,486 shares of the health services provider’s stock worth $350,000 after buying an additional 53 shares during the last quarter. Louisiana State Employees Retirement System increased its stake in LHC Group by 1.7% in the first quarter. Louisiana State Employees Retirement System now owns 6,100 shares of the health services provider’s stock worth $329,000 after buying an additional 100 shares during the last quarter. Mason Street Advisors LLC increased its stake in LHC Group by 7.0% in the first quarter. Mason Street Advisors LLC now owns 3,485 shares of the health services provider’s stock worth $188,000 after buying an additional 228 shares during the last quarter. Legal & General Group Plc increased its stake in LHC Group by 1.2% in the first quarter. Legal & General Group Plc now owns 25,087 shares of the health services provider’s stock worth $1,353,000 after buying an additional 290 shares during the last quarter. Finally, Thrivent Financial For Lutherans increased its stake in LHC Group by 4.1% in the first quarter. Thrivent Financial For Lutherans now owns 8,380 shares of the health services provider’s stock worth $452,000 after buying an additional 330 shares during the last quarter. 84.95% of the stock is owned by institutional investors and hedge funds.

LHC Group (LHCG) opened at 63.86 on Friday. LHC Group has a 52 week low of $32.04 and a 52 week high of $69.35. The company has a market capitalization of $1.17 billion, a PE ratio of 28.26 and a beta of 0.77. The company’s 50-day moving average price is $63.36 and its 200 day moving average price is $57.34.

LHC Group (NASDAQ:LHCG) last released its quarterly earnings data on Wednesday, August 2nd. The health services provider reported $0.63 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.09. The business had revenue of $260.20 million for the quarter, compared to analysts’ expectations of $254.10 million. LHC Group had a return on equity of 9.62% and a net margin of 4.13%. LHC Group’s quarterly revenue was up 15.1% on a year-over-year basis. During the same period in the previous year, the business posted $0.52 earnings per share. On average, equities research analysts anticipate that LHC Group will post $2.39 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This story was first published by Daily Political and is owned by of Daily Political. If you are accessing this story on another site, it was copied illegally and reposted in violation of U.S. and international copyright & trademark law. The original version of this story can be viewed at https://www.dailypolitical.com/2017/08/18/lhc-group-lhcg-stake-lowered-by-strs-ohio.html.

A number of analysts have recently weighed in on the stock. Stephens set a $69.00 price target on shares of LHC Group and gave the stock a “buy” rating in a research report on Saturday, May 6th. Royal Bank Of Canada restated a “buy” rating and set a $69.00 price objective on shares of LHC Group in a research note on Tuesday, July 18th. Zacks Investment Research upgraded LHC Group from a “hold” rating to a “buy” rating and set a $67.00 price objective on the stock in a research note on Saturday, August 5th. BidaskClub cut LHC Group from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 12th. Finally, Benchmark Co. raised their price objective on LHC Group from $63.00 to $72.00 and gave the stock a “buy” rating in a research note on Thursday, June 8th. One analyst has rated the stock with a hold rating and eight have given a buy rating to the company. LHC Group presently has an average rating of “Buy” and a consensus price target of $65.75.

In related news, COO Donald Dwayne Stelly sold 3,181 shares of the business’s stock in a transaction on Thursday, June 8th. The stock was sold at an average price of $64.97, for a total value of $206,669.57. Following the sale, the chief operating officer now owns 114,235 shares of the company’s stock, valued at approximately $7,421,847.95. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Coliseum Capital Management, L sold 162,524 shares of the business’s stock in a transaction on Wednesday, June 7th. The shares were sold at an average price of $62.80, for a total value of $10,206,507.20. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 546,207 shares of company stock worth $33,813,733. 14.80% of the stock is currently owned by company insiders.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group (NASDAQ:LHCG).

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.